Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1311506.RAfUl6I4Ow5fhLJgsd4SSdvjmkplrNGjPqJ9txR8fQ8SQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1311506.RAfUl6I4Ow5fhLJgsd4SSdvjmkplrNGjPqJ9txR8fQ8SQ130_assertion type Assertion NP1311506.RAfUl6I4Ow5fhLJgsd4SSdvjmkplrNGjPqJ9txR8fQ8SQ130_head.
- NP1311506.RAfUl6I4Ow5fhLJgsd4SSdvjmkplrNGjPqJ9txR8fQ8SQ130_assertion description "[Among the investigated CD44 splice variants expression of exon v6 is the most promising prognostic marker in surgically treated cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311506.RAfUl6I4Ow5fhLJgsd4SSdvjmkplrNGjPqJ9txR8fQ8SQ130_provenance.
- NP1311506.RAfUl6I4Ow5fhLJgsd4SSdvjmkplrNGjPqJ9txR8fQ8SQ130_assertion evidence source_evidence_literature NP1311506.RAfUl6I4Ow5fhLJgsd4SSdvjmkplrNGjPqJ9txR8fQ8SQ130_provenance.
- NP1311506.RAfUl6I4Ow5fhLJgsd4SSdvjmkplrNGjPqJ9txR8fQ8SQ130_assertion SIO_000772 7539775 NP1311506.RAfUl6I4Ow5fhLJgsd4SSdvjmkplrNGjPqJ9txR8fQ8SQ130_provenance.
- NP1311506.RAfUl6I4Ow5fhLJgsd4SSdvjmkplrNGjPqJ9txR8fQ8SQ130_assertion wasDerivedFrom befree-2016 NP1311506.RAfUl6I4Ow5fhLJgsd4SSdvjmkplrNGjPqJ9txR8fQ8SQ130_provenance.
- NP1311506.RAfUl6I4Ow5fhLJgsd4SSdvjmkplrNGjPqJ9txR8fQ8SQ130_assertion wasGeneratedBy ECO_0000203 NP1311506.RAfUl6I4Ow5fhLJgsd4SSdvjmkplrNGjPqJ9txR8fQ8SQ130_provenance.